Shree Ganesh Biotech (India) Limited

BSE: SHREEGANES539470ISIN INE051N01026

Healthcare
Biotechnology

Share price

₹0.44-0.02 (-4.35%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹0.75
52W low: ₹0.40
Off 52W high: -41.33%
1M return: -6.38%
3M return: -20.00%
6M return: -27.87%
1Y return: -39.73%
20D avg volume: 5,01,896
50 DMA: ₹0.47
200 DMA: ₹0.57

Key ratios Standalone

Market cap: ₹17.54 Cr
Current price: ₹0.44
52W high / low: ₹0.75 / ₹0.40
Face value: ₹1.00
P/E: -44.00
P/B: 0.28
EPS (TTM): ₹-0.01
Book value / share: ₹1.57
ROE: -0.76%
ROCE: 0.80%
Operating margin: -50.63%
Net margin: -50.63%
Debt / equity: 0.00
Net debt: ₹-0.01 Cr
Interest cover: —
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 861.5 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	0.16	1.43	2.12	0.70	0.77	1.38	3.01	14.41	1.98	3.56	—
	0.32	0.32	0.28	0.37	0.41	0.42	0.47	0.30	0.30	0.37	—
	0.48	1.75	2.40	1.07	1.18	1.80	3.47	14.72	2.29	3.92	—
	0.56	2.32	2.55	0.75	1.16	1.47	4.42	13.94	1.96	3.69	—
	0.28	1.87	2.16	0.66	1.12	1.12	3.52	13.76	1.92	3.44	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.04	0.06	0.04	0.07	0.03	0.01	0.01	0.06	0.01	0.01	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.24	0.40	0.34	0.01	0.01	0.34	0.88	0.12	0.03	0.24	—
	-0.08	-0.57	-0.15	0.32	0.01	0.33	-0.95	0.77	0.32	0.24	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	-0.08	-0.57	-0.15	0.32	0.01	0.33	-0.95	0.77	0.32	0.24	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	-0.08	-0.57	-0.15	0.32	0.01	0.33	-0.95	0.77	0.32	0.24	—
	0.00	-0.01	0.00	0.01	0.00	0.01	-0.02	0.02	0.01	0.01	—
Key metrics
	-0.08	-0.57	-0.15	0.32	0.01	0.33	-0.95	0.77	0.32	0.24	—
	-50.00%	-39.90%	-7.10%	45.70%	1.30%	23.90%	-31.60%	5.30%	16.20%	6.70%	—
	-50.00%	-39.90%	-7.10%	45.70%	1.30%	23.90%	-31.60%	5.30%	16.20%	6.70%	—
	-0.10%	—	-0.20%	—	0.00%	—	-1.50%	—	—	—	—
	-79.20%	3.60%	-29.60%	-95.10%	-61.10%	-61.20%	—	—	—	—	—
	-900.00%	-272.70%	84.20%	-58.40%	-96.90%	37.50%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	4.41	4.97	22.96	—
	1.29	1.47	1.44	—
	5.70	6.44	24.40	—
	6.18	5.93	24.01	—
	4.97	5.06	22.64	—
	0.00	0.00	0.00	—
	0.21	0.16	0.10	—
	0.00	0.00	0.00	—
	0.00	0.00	0.00	—
	0.99	0.71	1.27	—
	-0.48	0.51	0.39	—
	0.00	0.00	0.00	—
	-0.48	0.51	0.39	—
	0.00	0.14	0.11	—
	-0.48	0.38	0.28	—
	0.00	0.01	0.01	—
Key metrics
	-0.48	0.51	0.39	—
	-10.88%	10.30%	1.70%	—
	-10.88%	7.60%	1.20%	—
	—	0.80%	0.60%	—
	-77.47%	-78.40%	—	—
	-400.00%	35.70%	—	—
	—	-8.20	-10.21	—
	—	-21.58	-36.46	—
	—	0.00	0.00	—
	—	-0.01	-0.01	—
	—	861.5	45.9	—
Balance sheet
	—	63.80	63.49	—
	—	11.90	12.54	—
	—	0.01	0.01	—
	—	0.00	0.00	—
	—	11.73	2.89	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.17	0.23	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	63.63	63.26	—
Cash flow
	—	-8.20	-10.21	—
	—	8.19	9.80	—
	—	0.00	0.00	—
	—	0.00	0.00	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -77.47%
Profit YoY (TTM): -400.00%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 0.00%

Quarter	September 2026	June 2026
Promoter %	0.00%	0.00%

Holder	Type	Holding	Previous	Change
NEW ERA FUND LIMITED	Public	1.42%	1.42%	0.00%
GOPINATHAN NAIR GOPAL	Public	1.12%	—	—

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Anthem Biosciences Limited	50,022	887.45	81.45	26.80%	—	—	+26.33%
Advanced Enzyme Technologies Limited	3,121	278.70	17.39	13.60%	+10.31% TTM	+18.17% TTM	-11.17%
Ennature Bio Pharma Limited	584	261.25	—	—	—	—	—
CCME GLOBAL LIMITED S	163	35.93	-189.11	-1.80%	—	-124.71% TTM	-78.98%
Vivo Bio tech Ltd.	31	13.88	-10.78	7.20%	+12.33% TTM	-133.73% TTM	-56.96%
Shree Ganesh Biotech (India) Limited S	18	0.44	-44.00	0.80%	-77.47% TTM	-400.00% TTM	-39.73%
GENOMIC VALLEY BIOTECH LIMITED S	17	55.67	-5,567.00	1.00%	-80.30% TTM	-110.00% TTM	+56.46%

Filings & corporate actions

Recent announcements

PFA2 Nov 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
PFA2 Nov 2026 · Result / Financial Results
Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors ....2 Nov 2026 · Board Meeting / Outcome of Board Meeting
Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve Pursuant to Regulation ....23 Oct 2026 · Board Meeting / Board Meeting
PFA6 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
PFA28 Sep 2026 · AGM/EGM / AGM
PFA28 Sep 2026 · AGM/EGM / AGM
PFA17 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial ....3 Sep 2026 · Others / Reg. 34 (1) Annual Report
PFA3 Sep 2026 · Corp. Action / Book Closure
PFA3 Sep 2026 · AGM/EGM / AGM
PFA1 Sep 2026 · Company Update / General
PFA4 Aug 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
PFA4 Aug 2026 · Result / Financial Results
Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors ....4 Aug 2026 · Board Meeting / Outcome of Board Meeting
Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve Pursuant to Regulation ....21 Jul 2026 · Board Meeting / Board Meeting
PFA7 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
PFA12 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
PFA23 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
PFA14 May 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
PFA14 May 2026 · Result / Financial Results
This is to inform you that Outcome of the Board Meeting of the Company held on today i.e. Thursday 14th May 2026 in accordance with SEBl (Listing Obligations and Disclosures Requirements) ....14 May 2026 · Board Meeting / Outcome of Board Meeting
Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve Pursuant to Regulation ....4 May 2026 · Board Meeting / Board Meeting
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....23 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
PFA6 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
PFA17 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
PFA29 Jan 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
PFA29 Jan 2026 · Result / Financial Results
Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors ....29 Jan 2026 · Board Meeting / Outcome of Board Meeting
Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2026 ,inter alia, to consider and approve Pursuant to Regulation ....19 Jan 2026 · Board Meeting / Board Meeting
PFA5 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
PFA20 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
PFA8 Nov 2025 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
PFA8 Nov 2025 · Result / Financial Results
Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors ....8 Nov 2025 · Board Meeting / Outcome of Board Meeting
Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 ,inter alia, to consider and approve PFA30 Oct 2025 · Board Meeting / Board Meeting
PFA8 Oct 2025 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
PFA27 Sep 2025 · Insider Trading / SAST / Closure of Trading Window
PFA26 Sep 2025 · AGM/EGM / AGM
PFA26 Sep 2025 · AGM/EGM / AGM

Board meetings

2 Nov 2026 Board Meeting - Financial Results
4 Aug 2026 Board Meeting - Financial Results